LSC Webinars CELL All

  1. Translating Stem Cell Programs To GMP 3/4/2026

    A detailed exploration of challenges in advancing stem cell programs to GMP, highlighting strategies to control variability, strengthen process design, and support reliable clinical‑stage manufacturing.

  2. The Future Of CGT: Integrating Digitalization With Regulatory Readiness 3/3/2026

    Explore how cell and gene therapy manufacturers are scaling from batch‑of‑one to commercial supply while staying compliant, digital, and efficient, as well as strategies to strengthen quality.

  3. Four Common Pitfalls To Avoid In UF/DF Setup And Scale-Up 2/18/2026

    Learn how small UF/DF decisions can create major scale-up challenges, as well as practical ways to improve membrane selection, reduce manual operations, and boost PD–MSAT alignment.

  4. Bridging Discovery And CMC With Rapid Pools 2/10/2026

    Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection.

  5. Charting The Path To First-In-Human: Strategic Readiness For Early Clinical Success 2/10/2026

    Gain a comprehensive, end-to-end perspective on the journey to first-in-human and understand how early decisions influence downstream success.

  6. Selecting A Prefillable Syringe System With Confidence 2/5/2026

    Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.

  7. Simplified Harvest And Media Exchange In Cell Therapy 1/28/2026

    Scale-up often introduces shear stress and process variability. Learn how low-shear, single-use technology stabilizes media exchange and harvest, ensuring consistent cell quality and predictable performance.

  8. Next-Level Cell Lines: An Integrated Approach To Biologic Innovation 1/22/2026

    See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.

  9. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

    Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

  10. Overcoming Regulatory Hurdles In AAV Production 12/16/2025

    Demonstrating residual reagent clearance is a critical regulatory requirement in AAV manufacturing. Explore how specialized assays and strategic partnerships streamline compliance.